Showing results (101-110 of 154) with videos related to
Sort By:
Pageof 16
Anticancer Research|March 19, 2017
Impact of Maintenance Therapy for Patients with Non-small Cell Lung Cancer in a Real-world SettingKiyotaka Yoh, Yasushi Goto, Yoichi Naito, et al.Transplantation|March 13, 2002
Response-oriented preemptive therapy against cytomegalovirus disease with low-dose ganciclovir: a prospective evaluationYoshinobu Kanda, Shin Mineishi, Takeshi Saito, et al.Japanese Journal of Clinical Oncology|February 11, 2004
Study of paclitaxel and dose escalation of cisplatin in patients with advanced non-small cell lung cancerHirokazu Watanabe, Noboru Yamamoto, Tomohide Tamura, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 7, 2005
Epidermal growth factor receptor gene mutations and increased copy numbers predict gefitinib sensitivity in patients with recurrent non-small-cell lung cancerToshimi Takano, Yuichiro Ohe, Hiromi Sakamoto, et al.Journal of Geriatric Oncology|May 31, 2025
Longitudinal assessment of functional independence of older adults after lung cancer surgery: Final results of the JCOG1710A prospective cohort studyTomonori Mizutani, Hidefumi Takei, Hideo Kunitoh, et al.Drug Metabolism and Pharmacokinetics|March 3, 2009
Genetic variations and haplotype structures of the glutathione S-transferase genes, GSTT1 and GSTM1, in a Japanese patient populationNaoko Tatewaki, Keiko Maekawa, Noriko Katori, et al.Drug Metabolism and Pharmacokinetics|December 27, 2007
Genetic variations of VDR/NR1I1 encoding vitamin D receptor in a Japanese populationMaho Ukaji, Yoshiro Saito, Hiromi Fukushima-Uesaka, et al.Carcinogenesis|January 12, 2010
Individuals susceptible to lung adenocarcinoma defined by combined HLA-DQA1 and TERT genotypesTakashi Kohno, Hideo Kunitoh, Yoko Shimada, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 31, 2009
Circulating endothelial cells in non-small cell lung cancer patients treated with carboplatin and paclitaxelMakoto Kawaishi, Yutaka Fujiwara, Tomoya Fukui, et al.JTO Clinical and Research Reports|October 17, 2024
The Whole Picture of First-Line Osimertinib for EGFR Mutation-Positive Advanced NSCLC: Real-World Efficacy, Safety, Progression Pattern, and Posttreatment Therapy (Reiwa Study)Kageaki Watanabe, Yukio Hosomi, Katsuhiko Naoki, et al.Pageof 16